MedPath

Ultrasound Device for Hair Removal

Completed
Conditions
Hair Removal
Interventions
Device: Cutera Ultrasound Device
Registration Number
NCT01057134
Lead Sponsor
Cutera Inc.
Brief Summary

The purpose of this study is to evaluate the safety and efficacy of the Cutera UHAIR ultrasound device for hair removal.

Detailed Description

The purpose of this study is to evaluate the Cutera UHAIR device for safety and efficacy for removal and long term reduction of unwanted hair on subjects with Fitzpatrick skin types I-IV and dark (black or brown), red, and blonde colored hair.

At investigator's discretion, each subject will receive treatments and will be scheduled for follow-up visits after the final treatment. The treated area(s) will be photographed at each visit for analysis.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Male or female at least 18 years of age
  • Fitxpatrick skin type I-IV
  • Area with unwanted hair
  • Subject must be able to read, understand and sign the consent form
  • Subject must adhere to the follow-up schedule and study instruction
Exclusion Criteria
  • Simultaneous participation in any other clinical study
  • Inability or unwillingness to follow the treatment schedule
  • Inability or unwillingness to sign the informed consent
  • Infection in the target area
  • Any disease or condition that could impair wound healing
  • History of keloid formation
  • History of malignant tumors in the target area
  • Skin abnormalities in the target area, e.g. cuts, scrapes, wounds, scars, large moles
  • History of hair removal in target area (light based or electrolysis)
  • Pregnant or lactating

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Site treated with UHAIRCutera Ultrasound DeviceThe arm, calf, and thigh will be treated
Primary Outcome Measures
NameTimeMethod
Reduction in Hair Count in the Treated Areabaseline and 3 months post final treatment (up to 28 weeks)

Percent hair reduction 3 months post final treatment compared to baseline in the treated areas

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath